November 13, 2023
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacey Gama
| Re: |
PaxMedica, Inc. Withdrawal of Request for Acceleration of Registration Statement on Form S-1 File No. 333-275416 |
Dear. Ms. Gamma,
PaxMedica, Inc. (the “Company”) hereby withdraws its request, dated November 9, 2023, that the Registration Statement on Form S-1 (File No. 333-275416) (the “Registration Statement”) become effective on Monday, November 13, 2023, at 5:15 p.m. Eastern Time, or as soon thereafter as practicable. The Company is no longer requesting that the Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Anna Tomczyk of Dechert LLP at (212) 641-5626.
|
Sincerely,
PAXMEDICA, INC. | |
| /s/ Howard Weisman | |
|
Howard Weisman Chief Executive Officer |
| cc: | Anna Tomczyk, Dechert LLP |